WallStreetZenWallStreetZen

NASDAQ: CTMX
Cytomx Therapeutics Inc Earnings & Revenue

CTMX past revenue growth

How has CTMX's revenue growth performed historically?
Company
76.24%
Industry
89.94%
Market
19.39%
CTMX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
CTMX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
CTMX's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

CTMX earnings and revenue history

Current Revenue
$119.2M
Current Earnings
$16.5M
Current Profit Margin
13.9%

CTMX Return on Equity

Current Company
-30.7%
Current Industry
16.8%
Current Market
28.2%
CTMX's Return on Equity (-30.7%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when CTMX announces earnings.

CTMX Return on Assets

Current Company
8.1%
Current Industry
3.2%
CTMX is generating higher Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

CTMX Return on Capital Employed

Current Company
50.99%
Current Industry
-42.4%
CTMX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

CTMX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
CTMX$119.18M$26.34M$16.53M+9.76%N/A
ACET$0.00-$130.23M-$139.79M-100.00%N/A
IMAB$3.82M-$195.33M-$202.72M-12.91%N/A
RGLS$0.00-$30.61M-$31.37M-100.00%N/A
ADAG$18.11M-$14.94M-$18.95M+64.33%N/A

CTMX earnings dates

Next earnings date
Aug 6, 2024

Cytomx Therapeutics Earnings & Revenue FAQ

What were CTMX's earnings last quarter?

On Invalid Date, Cytomx Therapeutics (NASDAQ: CTMX) reported Q1 2024 earnings per share (EPS) of $0.17, up 440% year over year. Total Cytomx Therapeutics earnings for the quarter were $13.79 million. In the same quarter last year, Cytomx Therapeutics's earnings per share (EPS) was -$0.05.

If you're new to stock investing, here's how to buy Cytomx Therapeutics stock.

What was CTMX's earnings growth in the past year?

As of Q3 2024, Cytomx Therapeutics's earnings has grown year over year. Cytomx Therapeutics's earnings in the past year totalled $16.53 million.

What is CTMX's earnings date?

Cytomx Therapeutics's earnings date is Invalid Date. Add CTMX to your watchlist to be reminded of CTMX's next earnings announcement.

What was CTMX's revenue last quarter?

On Invalid Date, Cytomx Therapeutics (NASDAQ: CTMX) reported Q1 2024 revenue of $41.46 million up 76.45% year over year. In the same quarter last year, Cytomx Therapeutics's revenue was $23.50 million.

What was CTMX's revenue growth in the past year?

As of Q3 2024, Cytomx Therapeutics's revenue has grown 76.24% year over year. This is 13.7 percentage points lower than the US Biotechnology industry revenue growth rate of 89.94%. Cytomx Therapeutics's revenue in the past year totalled $119.18 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.